According to Altimmune's latest financial reports the company's total liabilities are $16.54 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $21.63 M | 9.66% |
2021-12-31 | $19.73 M | 2.55% |
2020-12-31 | $19.23 M | 125.34% |
2019-12-31 | $8.53 M | 32.62% |
2018-12-31 | $6.43 M | -55.14% |
2017-12-31 | $14.35 M | 131.75% |
2016-12-31 | $6.19 M | 92.73% |
2015-12-31 | $3.21 M | -13.25% |
2014-12-31 | $3.7 M | -62.22% |
2013-12-31 | $9.8 M | -11.42% |
2012-12-31 | $11.06 M | 59.21% |
2011-12-31 | $6.95 M | -53.62% |
2010-12-31 | $14.98 M | -53.42% |
2009-12-31 | $32.18 M | -14.02% |
2008-12-31 | $37.42 M | 43.74% |
2007-12-31 | $26.03 M | 56.7% |
2006-12-31 | $16.61 M | 18.79% |
2005-12-31 | $13.98 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | 3,663.25% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.01 M | -27.39% | ๐บ๐ธ USA |